Report Summary
The global Porcine Epidemic Diarrhea Vaccines market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Porcine Epidemic Diarrhea Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Porcine Epidemic Diarrhea Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Porcine Epidemic Diarrhea Vaccines in these regions.
This research report categorizes the global Porcine Epidemic Diarrhea Vaccines market by top players/brands, region, type and end user. This report also studies the global Porcine Epidemic Diarrhea Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CAVAC
Green Cross Veterinary Products
Harrisvaccines, Inc.
Komipharm
Nisseiken Co., Ltd.
Qilu Animal Health
Zoetis
Market size by Product
Live Vaccines
Killed Vaccines
Market size by End User
Piglets
Adults Pigs
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Porcine Epidemic Diarrhea Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Porcine Epidemic Diarrhea Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Porcine Epidemic Diarrhea Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Porcine Epidemic Diarrhea Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Porcine Epidemic Diarrhea Vaccines are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Porcine Epidemic Diarrhea Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Porcine Epidemic Diarrhea Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate by Product
1.4.2 Live Vaccines
1.4.3 Killed Vaccines
1.5 Market by End User
1.5.1 Global Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate by End User
1.5.2 Piglets
1.5.3 Adults Pigs
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Porcine Epidemic Diarrhea Vaccines Market Size
2.1.1 Global Porcine Epidemic Diarrhea Vaccines Revenue 2017-2027
2.1.2 Global Porcine Epidemic Diarrhea Vaccines Sales 2017-2027
2.2 Porcine Epidemic Diarrhea Vaccines Growth Rate by Regions
2.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Regions
2.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Porcine Epidemic Diarrhea Vaccines Sales by Manufacturers
3.1.1 Porcine Epidemic Diarrhea Vaccines Sales by Manufacturers
3.1.2 Porcine Epidemic Diarrhea Vaccines Sales Market Share by Manufacturers
3.1.3 Global Porcine Epidemic Diarrhea Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturers
3.2.1 Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturers (2017-2020)
3.2.2 Porcine Epidemic Diarrhea Vaccines Revenue Share by Manufacturers (2017-2020)
3.3 Porcine Epidemic Diarrhea Vaccines Price by Manufacturers
3.4 Porcine Epidemic Diarrhea Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Porcine Epidemic Diarrhea Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Porcine Epidemic Diarrhea Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Porcine Epidemic Diarrhea Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Product
4.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Product
4.3 Porcine Epidemic Diarrhea Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Porcine Epidemic Diarrhea Vaccines Breakdown Data by End User
6 North America
6.1 North America Porcine Epidemic Diarrhea Vaccines by Countries
6.1.1 North America Porcine Epidemic Diarrhea Vaccines Sales by Countries
6.1.2 North America Porcine Epidemic Diarrhea Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Porcine Epidemic Diarrhea Vaccines by Product
6.3 North America Porcine Epidemic Diarrhea Vaccines by End User
7 Europe
7.1 Europe Porcine Epidemic Diarrhea Vaccines by Countries
7.1.1 Europe Porcine Epidemic Diarrhea Vaccines Sales by Countries
7.1.2 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Porcine Epidemic Diarrhea Vaccines by Product
7.3 Europe Porcine Epidemic Diarrhea Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines by Countries
8.1.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Countries
8.1.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines by Product
8.3 Asia Pacific Porcine Epidemic Diarrhea Vaccines by End User
9 Central & South America
9.1 Central & South America Porcine Epidemic Diarrhea Vaccines by Countries
9.1.1 Central & South America Porcine Epidemic Diarrhea Vaccines Sales by Countries
9.1.2 Central & South America Porcine Epidemic Diarrhea Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Porcine Epidemic Diarrhea Vaccines by Product
9.3 Central & South America Porcine Epidemic Diarrhea Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines by Countries
10.1.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Countries
10.1.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines by Product
10.3 Middle East and Africa Porcine Epidemic Diarrhea Vaccines by End User
11 Company Profiles
11.1 CAVAC
11.1.1 CAVAC Company Details
11.1.2 Company Business Overview
11.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Products Offered
11.1.5 CAVAC Recent Development
11.2 Green Cross Veterinary Products
11.2.1 Green Cross Veterinary Products Company Details
11.2.2 Company Business Overview
11.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Products Offered
11.2.5 Green Cross Veterinary Products Recent Development
11.3 Harrisvaccines, Inc.
11.3.1 Harrisvaccines, Inc. Company Details
11.3.2 Company Business Overview
11.3.3 Harrisvaccines, Inc. Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Harrisvaccines, Inc. Porcine Epidemic Diarrhea Vaccines Products Offered
11.3.5 Harrisvaccines, Inc. Recent Development
11.4 Komipharm
11.4.1 Komipharm Company Details
11.4.2 Company Business Overview
11.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Products Offered
11.4.5 Komipharm Recent Development
11.5 Nisseiken Co., Ltd.
11.5.1 Nisseiken Co., Ltd. Company Details
11.5.2 Company Business Overview
11.5.3 Nisseiken Co., Ltd. Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Nisseiken Co., Ltd. Porcine Epidemic Diarrhea Vaccines Products Offered
11.5.5 Nisseiken Co., Ltd. Recent Development
11.6 Qilu Animal Health
11.6.1 Qilu Animal Health Company Details
11.6.2 Company Business Overview
11.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Products Offered
11.6.5 Qilu Animal Health Recent Development
11.7 Zoetis
11.7.1 Zoetis Company Details
11.7.2 Company Business Overview
11.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Zoetis Porcine Epidemic Diarrhea Vaccines Products Offered
11.7.5 Zoetis Recent Development
12 Future Forecast
12.1 Porcine Epidemic Diarrhea Vaccines Market Forecast by Regions
12.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales Forecast by Regions 2021-2027
12.1.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Forecast by Regions 2021-2027
12.2 Porcine Epidemic Diarrhea Vaccines Market Forecast by Product
12.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales Forecast by Product 2021-2027
12.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Forecast by Product 2021-2027
12.3 Porcine Epidemic Diarrhea Vaccines Market Forecast by End User
12.4 North America Porcine Epidemic Diarrhea Vaccines Forecast
12.5 Europe Porcine Epidemic Diarrhea Vaccines Forecast
12.6 Asia Pacific Porcine Epidemic Diarrhea Vaccines Forecast
12.7 Central & South America Porcine Epidemic Diarrhea Vaccines Forecast
12.8 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Porcine Epidemic Diarrhea Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
